Eansor Norman David 4
4 · Marker Therapeutics, Inc. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
EANSOR N DAVID
Director
Transactions
- Purchase
Common Stock
2021-03-16$17.50/sh+14,285$249,988→ 16,713 total - Gift
Common Stock
2021-03-25−14,285→ 2,428 total - Gift
Common Stock
2021-03-25+7,142→ 7,142 total(indirect: By Trust) - Gift
Common Stock
2021-03-25+7,142→ 7,142 total(indirect: By Trust) - Award
Stock Option (right to buy)
2023-06-06+8,000→ 8,000 totalExercise: $1.72Exp: 2033-06-05→ Common Stock (8,000 underlying)
Footnotes (3)
- [F1]Reflects a 10-1 reverse stock split which became effective on January 16, 2023.
- [F2]The Reporting Person transferred these shares to a trust of which the Reporting Person is the trustee. The Reporting Person's immediate family is the sole beneficiary of the trust.
- [F3]This option vests on June 6, 2024, subject to the Reporting Person's continued service as a director through the vesting date.